Stockscreener 앱 받기
4.94
2.70%
0.13
시장 영업 전:
4.94
전일 마감가:
$4.81
열려 있는:
$4.82
하루 거래량:
8.09M
Relative Volume:
1.13
시가총액:
$2.60B
수익:
$2.21B
순이익/손실:
$-56.94M
주가수익비율:
-43.95
EPS:
-0.1124
순현금흐름:
$54.54M
1주 성능:
+15.15%
1개월 성능:
+42.36%
6개월 성능:
+87.12%
1년 성능:
+69.18%
1일 변동 폭
$4.805
$5.06
1주일 범위
$4.50
$5.18
52주 변동 폭
$1.58
$5.18
Clover Health Investments Corp Stock (CLOV) Company Profile
명칭
Clover Health Investments Corp
전화
(201) 432-2133
주소
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, ELV, CI, HUM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
4.94 | 2.53B | 2.21B | -56.94M | 54.54M | -0.1124 |
UNH
Unitedhealth Group Inc
|
407.65 | 373.28B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
100.72 | 128.46B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
397.80 | 87.28B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
291.88 | 77.73B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
369.49 | 45.65B | 137.20B | 1.15B | 1.27B | 9.3439 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 개시 | Craig Hallum | Buy |
| 2024-10-07 | 개시 | UBS | Neutral |
| 2022-02-02 | 개시 | Canaccord Genuity | Buy |
| 2022-02-02 | 업그레이드 | Cowen | Underperform → Market Perform |
| 2022-01-19 | 개시 | SVB Leerink | Mkt Perform |
| 2022-01-10 | 재개 | Citigroup | Neutral |
| 2022-01-07 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | 개시 | Cowen | Underperform |
| 2021-09-02 | 재개 | Citigroup | Neutral |
| 2021-07-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-06-10 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-05-17 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-02-02 | 개시 | Citigroup | Buy |
| 2021-02-01 | 개시 | JP Morgan | Neutral |
모두보기
Clover Health Investments Corp 주식(CLOV)의 최신 뉴스
Clover Health (NASDAQ: CLOV) RSU vesting lists 5,342 Class A shares for sale - Stock Titan
Clover Health (NASDAQ: CLOV) files Form 144 for 7,556 vested shares - Stock Titan
Clover Health gets Medicare star rating upgrade - MSN
Clover Health Stockholders Approve Directors and Executive Pay - TipRanks
Clover Health (CLOV) stockholders approve directors, pay and 2026 auditor - Stock Titan
Insider Sell: Jamie Reynoso Sells Shares of Clover Health Investments Corp - GuruFocus
Clover Health CEO Jamie Reynoso sells $35,788 of CLOV common stock - Investing.com India
CLOV Maintained by UBS -- Price Target Raised to $4.75 - GuruFocus
Clover Health (NASDAQ: CLOV) exec sells 7,289 shares under 10b5-1 plan - Stock Titan
[144] CLOVER HEALTH INVESTMENTS, CORP. /DE SEC Filing - Stock Titan
Health Care Notes: Clover star rating raised after court-ordered recalculation - InsuranceNewsNet
Clover Health (CLOV) Stock Jumps 14% on Medicare Star Rating Boost to 4.5 - Blockonomi
Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating - Benzinga
Clover Health Up Again After CMS Star Rating Shift Alters 2027 Payment View - TechStock²
Top Biotech Gainers: PBLS Soars Over 50%, CLOV Rallies On Legal Win, RNAZ, TMCI On Watch - RTTNews
Clover Health (CLOV)Hits Fresh Peak on Unexpected CMS Rating - Insider Monkey
Clover Health (CLOV) Sees Notable Increase in Share Price - GuruFocus
Clover Health (CLOV) Sees 10% Surge After Medicare Star Rating U - GuruFocus
CLOV: Clover Health Wins Legal Battle, Receives Boost in Star Ra - GuruFocus
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Why is Clover Health Investments stock surging today? By Investing.com - Investing.com India
A Court Order Sent CLOV Stock To Over 4.5-Year Highs – Retail Says The Implications Could Be Industry-Wide - Yahoo Finance
Clover Health stock jumps after Medicare rating upgrade - Investing.com
Caseys General Stores Upbeat Q4 Earnings, Joins Applied Optoelectronics, Clover Health Investments And Ot - Benzinga
Clover Health gets Medicare Star Rating upgrade (CLOV:NASDAQ) - Seeking Alpha
Clover Health stock jumps after Medicare rating upgrade By Investing.com - Investing.com Australia
Clover Health Investments sees PPO Star rating revised to 4.5 Stars after court order - TradingView
[8-K] CLOVER HEALTH INVESTMENTS, CORP. /DE Reports Material Event - Stock Titan
Spotlight On Promising Penny Stocks For June 2026 - Yahoo Finance
Clover Health stock hits 52-week high at 4.24 USD By Investing.com - Investing.com India
5 Stocks Surviving Market Slaughter - Insider Monkey
Clover Health stock hits 52-week high at 4.24 USD - Investing.com
3 Growth Stocks With High Insider Ownership And 29% Revenue Growth - simplywall.st
Clover targets 100-150 bps SG&A improvement in 2026 while expecting full-year GAAP net income profitability - MSN
Clover Health in the spotlight as earnings test profitability path - Investing.com
A Clover Health Insider Sold Over 220,000 Company Shares. What Does That Mean for Investors? - The Motley Fool
A Clover Health Insider Sold Over 220,000 Company Shares. What Does That Mean for Investors? - The Motley Fool
Earnings call transcript: Clover Health Q1 2026 sees revenue beat, EPS miss - Investing.com
Clover Health Q1 2026 slides: revenue surges 62%, profitability returns - Investing.com
Clover Health in the spotlight as earnings test profitability path By Investing.com - Investing.com Nigeria
CLOV Maintained by Canaccord Genuity -- Price Target Raised to $4.20 - GuruFocus
Why Clover Health (CLOV) Stock Is Up Today - Barchart
Clover Health Investments (BSP:CLOV34) Cyclically Adjusted PS Ratio : (As of Jun. 03, 2026) - GuruFocus
Clover Health Investments Corp (BSP:CLOV34) Stock Earnings Transcripts - GuruFocus
Breaking News: Rosen, Global Investor Counsel, Encourages Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III Investors with Losses over $100K to Secure Counsel Before Important DeadlineCLOV, CLOVW, IPOC - TMX Newsfile
Clover Health Investments Corp (CLOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Clover Health Investments Corp 주식 (CLOV) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Reynoso Jamie L. | CEO, Medicare Advantage |
Jun 15 '26 |
Sale |
4.61 |
6,350 |
29,274 |
2,843,571 |
4.15%
1.99%
자본화:
|
볼륨(24시간):